Bismuth Bicycles

Area of Science:

• Medicinal Chemistry
• Biotechnology
• Inorganic Chemistry

Background:

• Bicyclic peptides combine antibody-like affinity and specificity with small molecule synthetic ease.
• Phage display facilitates the discovery of high-affinity bicyclic peptides for diverse protein targets.
• Traditional bicyclic peptide generation involves reacting three cysteines with a C3-symmetric alkylating agent.

Purpose of the Study:

• To review the discovery and evolution of bicyclic peptides as therapeutics.
• To highlight the emergence of bismuth-based bicyclic peptides.
• To explore the future applications of bismuth bicycle molecules in medicine.

Main Methods:

• Phage display technology for library generation.
• Chemical modification of peptides using C3-symmetric agents.
• Exploration of inorganic scaffolds, specifically bismuth, for peptide cyclization.

Main Results:

• Bicyclic peptides serve as effective protein mimetics, binding challenging protein surfaces.
• A novel class of bicyclic peptides utilizing bismuth has been developed.
• This innovation bridges inorganic chemistry and biology for novel therapeutic design.

Conclusions:

• Bicyclic peptides represent a promising next-generation therapeutic modality.
• Bismuth bicyclic peptides open new avenues in drug discovery by expanding chemical space.
• Further research into bismuth bicycle molecules holds significant therapeutic potential.